Sign in or register to access exclusive content on this site
REGISTER

Publication: Deriving vignettes for the rare disease AADC deficiency using parent, caregiver and clinician interviews to evaluate the impact on health-related quality of life

This research article, published in Journal of Patient-Reported Outcomes, describes the 5-stage development of vignettes describing aromatic L-amino acid decarboxylase (AADC), for use in a subsequent health-state utility elicitation study

  • Learn about the process of development of a symptoms matrix and draft vignettes describing AADC deficiency motor milestones
  • Understand how hypothetical health-state vignettes can subsequently be used to develop health-state utilities for AADC deficiency
  • Recognize the potential importance of health-state utilities in capturing what it is like to live with AADC deficiency, and their utility in economic modelling to investigate the cost-effectiveness of AADC deficiency treatments

Hanbury A, et al. Patient Relat Outcome Meas. 2021;12:1–12

Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.

Fast-track access

Don't have an NPI number? Switch to manual verification
MED-US-CORP-2600009 | September 2026

Register now:

This field is for validation purposes and should be left unchanged.
  • This Website is intended only for healthcare professionals (“Website“), is operated by PTC Therapeutics. (together with its affiliates “PTC”). In order to access the restricted content on this Website:
* indicates a required field
Back to NPI verification
MED-US-CORP-2600009 | September 2026
MED-US-AADC-2600007 | February 2026

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This website may include scientific information about investigational and unlicensed products not approved for use within your country. Please refer to local regulatory guidance for country-specific information

© 2026 PTC Therapeutics. All rights reserved | MED-US-CORP-2600001 | February 2026

This content is protected.

To view it please enter your email address or NPI number below:

Register here to access the content on the site

MED-US-CORP-2600009 | September 2026

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.